Cbd Global Sciences Stock Current Valuation
| CBDNFDelisted Stock | USD 0.06 0.00 0.00% |
Valuation analysis of CBD Global Sciences helps investors to measure CBD Global's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that CBD Global's price fluctuation is very steady at this time. Calculation of the real value of CBD Global Sciences is based on 3 months time horizon. Increasing CBD Global's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CBD pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CBD Global Sciences. Since CBD Global is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CBD Pink Sheet. However, CBD Global's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.06 | Real 0.0538 | Hype 0.06 |
The real value of CBD Pink Sheet, also known as its intrinsic value, is the underlying worth of CBD Global Sciences Company, which is reflected in its stock price. It is based on CBD Global's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CBD Global's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CBD Global Sciences helps investors to forecast how CBD pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CBD Global more accurately as focusing exclusively on CBD Global's fundamentals will not take into account other important factors: CBD Global Sciences Company Current Valuation Analysis
CBD Global's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CBD Global Current Valuation | 14.44 M |
Most of CBD Global's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CBD Global Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, CBD Global Sciences has a Current Valuation of 14.44 M. This is 99.9% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.91% higher than that of the company.
CBD Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CBD Global's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CBD Global could also be used in its relative valuation, which is a method of valuing CBD Global by comparing valuation metrics of similar companies.CBD Global is currently under evaluation in current valuation category among its peers.
CBD Fundamentals
| Return On Asset | -1.38 | |||
| Operating Margin | (2.71) % | |||
| Current Valuation | 14.44 M | |||
| Shares Outstanding | 49.46 M | |||
| Shares Owned By Insiders | 26.61 % | |||
| Price To Sales | 2.79 X | |||
| Revenue | 166.95 K | |||
| Gross Profit | 3.61 K | |||
| EBITDA | (4.6 M) | |||
| Net Income | (5.25 M) | |||
| Cash And Equivalents | 59.92 K | |||
| Total Debt | 1.34 M | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | (0.26) X | |||
| Cash Flow From Operations | (1.14 M) | |||
| Earnings Per Share | (0.11) X | |||
| Beta | 0.49 | |||
| Market Capitalization | 5.93 M | |||
| Total Asset | 2.09 M | |||
| Z Score | -4.2 | |||
| Net Asset | 2.09 M |
About CBD Global Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CBD Global Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CBD Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CBD Global Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in CBD Pink Sheet
If you are still planning to invest in CBD Global Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CBD Global's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |